Trial intelligence / Profile preview

Plasma and synovial fluid pharmacokinetics of cefuroxime and linezolid in elective knee arthroscopy

2012-000379-18Phase 4Completed

Sponsor
Department of Clinical Pharmacology, Medical University of Vienna
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of cefuroxime and linezolid in bacterial disease, sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoint: AUCsynovia / AUCplasma ratio. Started Mar 2012; status: completed.

02

Drugs

cefuroximelinezolid
03

Conditions

bacterial disease

Beyond the preview

Go deeper on 2012-000379-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000379-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call